APA (7th ed.) Citation

ML, N., TJ, W., LM, S., BG, H., RJ, A., F, H., . . . AK, E. (2014). Add-on histamine receptor-3 antagonist for allergic rhinitis: A double blind randomized crossover trial using the environmental exposure unit. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 10(1), 33. https://doi.org/10.1186/1710-1492-10-33

Chicago Style (17th ed.) Citation

ML, North, Walker TJ, Steacy LM, Hobsbawn BG, Allan RJ, Hackman F, Sun X, Day AG, and Ellis AK. "Add-on Histamine Receptor-3 Antagonist for Allergic Rhinitis: A Double Blind Randomized Crossover Trial Using the Environmental Exposure Unit." Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology 10, no. 1 (2014): 33. https://doi.org/10.1186/1710-1492-10-33.

MLA (9th ed.) Citation

ML, North, et al. "Add-on Histamine Receptor-3 Antagonist for Allergic Rhinitis: A Double Blind Randomized Crossover Trial Using the Environmental Exposure Unit." Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology, vol. 10, no. 1, 2014, p. 33, https://doi.org/10.1186/1710-1492-10-33.